Procyon Corp (OTC:PCYN)

Procyon Corporation, through its subsidiaries, develops and markets proprietary medical products for use in the treatment of pressure ulcers, dermatitis, inflammation, and other skin problems. The company offers AmeriGel Hydrogel Wound Dressing and Amerigel Hydrogel Saturated Gauze Dressing, which are used as a wound dressing to manage stages I-IV pressure ulcers, stasis ulcers, diabetic skin ulcers, post-surgical incisions, cuts, abrasions, first and second degree burns, and skin irritations. It also provides Amerigel Premium Care Lotion, a therapeutic skin conditioner containing emollients that restore moisture to fragile skin and alleviate problematic skin conditions. In addition, the company offers Amerigel Barrier Lotion, which provides barrier protection to shield the skin from excess moisture and reduce harmful effects to the skin from friction and chafing; Amerigel Wound Wash, a sterile solution used for wound cleansing; and the AmeriGel Post Op Surgical Kit. Procyon Corporation sells its products through distributors to hospitals, nursing homes, home health care agencies, and health care practioners; and to retailers, including national and regional chain stores, as well as independent retail pharmacies. The company was incorporated in 1987 and is based in Clearwater, Florida.